Results 311 to 320 of about 1,109,815 (338)
Some of the next articles are maybe not open access.
Herbal medicine and cardiovascular diseases
Therapeutische Umschau, 2002Phytotherapeutika werden häufig von Patienten mit kardiovaskulären Problemen eingenommen. Ihr Nutzen ist umstritten, da die Datenlage der meisten Substanzen ungenügend ist. Für die drei Substanzen Ginkgo biloba, Crataegus und Knoblauch existieren aber eine Vielzahl von experimentellen und klinischen Studien, welche teilweise den Kriterien der Evidence-
Zbinden S, Seiler Ch
openaire +3 more sources
Pharmacoeconomics of Cardiovascular Medicine
2001The growth of managed care in the 1980s and 1990s and the resulting emphasis on cost containment have impacted the practice of cardiovascular medicine as we enter the twenty-first century. In this age of limited economic resources, it is no longer appropriate to embrace all advancements, however minor, in health care technology.
R Corey +2 more
openaire +2 more sources
2019
The field of cardiovascular medicine is an inexhaustible source for clinical trials (→ OHCM 10th edition:). The most feasible way of keeping up to date is referring to guidelines. In addition to those made available by the National Institute for Health and Care Excellence (NICE), the European Society of Cardiology (ESC) provides very useful Clinical ...
openaire +1 more source
The field of cardiovascular medicine is an inexhaustible source for clinical trials (→ OHCM 10th edition:). The most feasible way of keeping up to date is referring to guidelines. In addition to those made available by the National Institute for Health and Care Excellence (NICE), the European Society of Cardiology (ESC) provides very useful Clinical ...
openaire +1 more source
Pharmacogenetics in Cardiovascular Medicine
2018Considerable interindividual variability in response to cardiovascular pharmacotherapy exists with drug responses varying from being efficacious to inadequate to induce severe adverse events. Fueled by advancements and multidisciplinary collaboration across disciplines such as genetics, bioinformatics, and basic research, the vision of personalized ...
openaire +3 more sources
The challenge of polypharmacy in cardiovascular medicine
Fundamental & Clinical Pharmacology, 2010AbstractAlbeit great efforts in reducing the burden of cardiovascular diseases (CVD), their prevalence continues to grow worldwide. Among the causes for this rising burden, the upcoming pandemic of obesity and diabetes further enhances the estimates of CV mortality and healthcare costs over the next decades.
VOLPE, Massimo +2 more
openaire +4 more sources
Clinical management of metastatic colorectal cancer in the era of precision medicine
Ca-A Cancer Journal for Clinicians, 2022Fortunato Ciardiello +2 more
exaly
Radiotheranostics in oncology: Making precision medicine possible
Ca-A Cancer Journal for Clinicians, 2023Eric O Aboagye
exaly
Integrative oncology: Addressing the global challenges of cancer prevention and treatment
Ca-A Cancer Journal for Clinicians, 2022Paulo Cáceres Guido +2 more
exaly
Molecular imaging in oncology: Current impact and future directions
Ca-A Cancer Journal for Clinicians, 2022Martin G Pomper, Steven P Rowe
exaly